Herceptin-platinum(II) binding complexes: Novel cancer-cell-specific agents

ChemMedChem

Volumn 3, Issue 6, 2008, Pages 954-962

  Gao, Jian ^a,b   Liu, Ya Guang ^b   Liu, Renbin ^c   Zingaro, Ralph A ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antibodies; Apoptosis; Cancer; Her2 neu; mRNA; Platinum(II) compounds

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; PLATINUM COMPLEX; TRASTUZUMAB;

ARTICLE; CELL PROLIFERATION; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; HUMAN; REPRODUCIBILITY; STEREOISOMERISM; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR CONFORMATION; ORGANOPLATINUM COMPOUNDS; RECEPTOR, ERBB-2; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM;

EID: 48149090936     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.200700349     Document Type: Article

References (19)

1. D. B. Shenoy, M. M. Amiji, Int. J. Pharm. 2005, 293, 261-270.
2. K. Kataoka, A. Harada, Y. Nagasaki, Adv. Drug Delivery Rev. 2001, 47, 113-131.
3. S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe, R. Sasisekharan, Nature 2005, 436, 568-572.
4. J. Kreuter, Adv. Drug Delivery Rev. 2001, 47, 65-81.
5. S. Jaracz, J. Chen, L. V. Kuznetsova, I. Ojima, Bioorg. Med. Chem. 2005, 13, 5043-5054.
6. R. V. Chari, Adv. Drug Delivery Rev. 1998, 31, 89-104.
7. D. Schrama, R. A. Reisfeld, J. C. Becker, Nat. Rev. Drug Discovery 2006, 5, 147-159.
8. A. M. Wu, P. D. Senter, Nat. Biotechnol. 2005, 23, 1137-1146.
9. J. Chen, S. Jaracz, X. Zhao, S. Chen, I. Ojima, Expert Opin. Drug Delivery 2005, 2, 873-890.
10. H. S. Cho, K. Mason, K. X. Ramyar, A. M. Stanley, S. B. Gabelli, D. W. Denney, D. J. Leahy, Jr., Nature 2003, 421, 756-760.
11. N. E. Hynes, H. A. Lane, Nat. Rev. Cancer 2005, 5, 341-354.
12. S. J. Chiu, N. T. Ueno, R. J. Lee, J. Controlled Release 2004, 97, 357-369.
13. A. A. Bogan, K. S. Thorn, J. Mol. Biol. 1998, 280, 1-9.
14. P. A. Trail, D. Willner, S. J. Lasch, A. J. Henderson, S. Hofstead, A. M. Casazza, R. A. Firestone, I. Hellstrom, K. E. Hellstrom, Science 1993, 261, 212-215.
15. G. Payne, Cancer Cell 2003, 3, 207-212.
16. D. Harari, Y. Yarden, Oncogene 2000, 19, 6102-6114.
17. M. X. Sliwkowski, J. A. Lofgren, G. D. Lewis, T. E. Hotaling, B. M. Fendly, J. A. Fox, Semin. Oncol. 1999, 26(4Suppl. 12), 60-70.
18. G. M. Dubowchik, M. A. Walker, Pharmacol. Ther. 1999, 83, 67-123.
19. J. Gao, Y.-G. Liu, Y. Zhou, R. A. Zingaro, ChemMedChem 2007, 2, 1723-1729.